Healthcare professionals are invited to register for the livestream option as a courtesy here Smith+Nephew (LSE:SN, NYSE:SNN) ...

Barclays analyst Hassan Al-Wakeel maintained a Hold rating on Smith & Nephew (SN – Research Report) today and set a price target of £11.70.

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the inaugural Smith+Nephew UFC Combat Sports Medicine Course to be held in Las Vegas, Nevada from February ...

Smith+Nephew PLC (LSE: SN, NYSE: SNN), a leading medical technology company with a "GOOD" Financial Health score according to InvestingPro, is scheduled to release its full year results for the period ...

one company. The LEGION family offers a variety of options for both primary and revision total knee replacements. LEGION implants are available with VERILAST Technology, the combination of ...

DUBLIN--(BUSINESS WIRE)--The "Viscosupplementation Market, Global Forecast Report by Product, By Application, by End User, Regions and Company Analysis 2025-2033" report has been added to ...

The "Cartilage Regeneration Market by Type, by Treatment Modality, by Application Site, by Surgical Procedure, by End-user, ...

TIL that the term fast fashion was first coined almost 40 years ago and that Panda Express invented Orange Chicken.

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

It makes sense then that Smith+Nephew, a specialist in advanced wound ... with the main contest due to start on 1st July. The company unveiled its new Life Unlimited campaign this week ...

Medical equipment company Smith & Nephew has agreed a $660 million deal to buy US biotech Osiris Therapeutics that expands its business into regenerative medicine. Osiris makes medical products ...